Calcineurin Inhibition and Cardiac Hypertrophy: a Matter of Balance

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2001 Mar 15

PMID 11248009

Citations 15

Authors

L A Leinwand

Affiliations

Soon will be listed here.

Citing Articles

S100a8/9 (S100 Calcium Binding Protein a8/9) Promotes Cardiac Hypertrophy Via Upregulation of FGF23 (Fibroblast Growth Factor 23) in Mice.

Yuan Y, Shen Z, Teng T, Xu S, Kong C, Zeng X J Am Heart Assoc. 2024; 13(10):e028006.

PMID: 38726894 PMC: 11179804. DOI: 10.1161/JAHA.122.028006.

Case report: A novel truncating mutation within the regulatory domain causes severe developmental and epileptic encephalopathy in a Chinese patient.

Li J, Cao J Front Neurol. 2022; 13:889167.

PMID: 36158964 PMC: 9491239. DOI: 10.3389/fneur.2022.889167.

Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.

Matsa E, Burridge P, Yu K, Ahrens J, Termglinchan V, Wu H Cell Stem Cell. 2016; 19(3):311-25.

PMID: 27545504 PMC: 5087997. DOI: 10.1016/j.stem.2016.07.006.

IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling.

Jiang D, Wei X, Zhang X, Liu Y, Zhang Y, Chen K Nat Commun. 2014; 5:3303.

PMID: 24526256 PMC: 3929801. DOI: 10.1038/ncomms4303.

Calcineurin activity in children with Mental handicap.

Bindu L, Rani P, Reddy P Indian J Clin Biochem. 2012; 22(2):32-5.

PMID: 23105678 PMC: 3453820. DOI: 10.1007/BF02913309.

References

Taigen T, de Windt L, Lim H, Molkentin J . Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2000; 97(3):1196-201. PMC: 15566. DOI: 10.1073/pnas.97.3.1196. View

Meguro T, Hong C, Asai K, TAKAGI G, McKinsey T, Olson E . Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res. 1999; 84(6):735-40. DOI: 10.1161/01.res.84.6.735. View

Shimoyama M, Hayashi D, Takimoto E, Zou Y, Oka T, Uozumi H . Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation. 1999; 100(24):2449-54. DOI: 10.1161/01.cir.100.24.2449. View

Zhang W, Kowal R, Rusnak F, Sikkink R, Olson E, Victor R . Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999; 84(6):722-8. DOI: 10.1161/01.res.84.6.722. View

Rothermel B, McKinsey T, Vega R, Nicol R, Mammen P, Yang J . Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A. 2001; 98(6):3328-33. PMC: 30653. DOI: 10.1073/pnas.041614798. View

DuBell W, Gaa S, Lederer W, Rogers T . Independent inhibition of calcineurin and K+ currents by the immunosuppressant FK-506 in rat ventricle. Am J Physiol. 1998; 275(6):H2041-52. DOI: 10.1152/ajpheart.1998.275.6.H2041. View

Murat A, Pellieux C, Brunner H, Pedrazzini T . Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J Biol Chem. 2000; 275(52):40867-73. DOI: 10.1074/jbc.M008071200. View

Chin E, Olson E, Richardson J, Yang Q, Humphries C, Shelton J . A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998; 12(16):2499-509. PMC: 317085. DOI: 10.1101/gad.12.16.2499. View

Molkentin J, Lu J, Antos C, Markham B, Richardson J, Robbins J . A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998; 93(2):215-28. PMC: 4459646. DOI: 10.1016/s0092-8674(00)81573-1. View

10.

Lipkin G, Tucker B, Giles M, Raine A . Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J Hypertens. 1993; 11(4):439-42. DOI: 10.1097/00004872-199304000-00015. View

11.

Rothermel B, Vega R, Yang J, Wu H, Bassel-Duby R, Williams R . A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem. 2000; 275(12):8719-25. DOI: 10.1074/jbc.275.12.8719. View

12.

Sussman M, Lim H, Gude N, Taigen T, Olson E, Robbins J . Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998; 281(5383):1690-3. DOI: 10.1126/science.281.5383.1690. View

13.

Kaibori M, Okumura T, Ito S, Oda M, Inoue T, Kamiyama Y . Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. Transplant Proc. 1999; 31(1-2):804-5. DOI: 10.1016/s0041-1345(98)01778-3. View

14.

de Windt L, Lim H, Bueno O, Liang Q, Delling U, Braz J . Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A. 2001; 98(6):3322-7. PMC: 30652. DOI: 10.1073/pnas.031371998. View

15.

Yang J, Rothermel B, Vega R, Frey N, McKinsey T, Olson E . Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res. 2000; 87(12):E61-8. DOI: 10.1161/01.res.87.12.e61. View

16.

Aperia A, Ibarra F, Svensson L, Klee C, Greengard P . Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells. Proc Natl Acad Sci U S A. 1992; 89(16):7394-7. PMC: 49716. DOI: 10.1073/pnas.89.16.7394. View

17.

Ding B, Price R, Borg T, Weinberg E, Halloran P, Lorell B . Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res. 1999; 84(6):729-34. DOI: 10.1161/01.res.84.6.729. View

18.

Mesaeli N, Nakamura K, Zvaritch E, Dickie P, Dziak E, Krause K . Calreticulin is essential for cardiac development. J Cell Biol. 1999; 144(5):857-68. PMC: 2148186. DOI: 10.1083/jcb.144.5.857. View